German chemicals giant Bayer yesterday said it had increased its earnings and profits forecasts after signing a deal to take over US seeds and pesticides maker Monsanto.
“We are optimistic for the medium-term development of Bayer and have set ourselves correspondingly ambitious targets,” chief executive Werner Baumann said in a statement.
In the crop science division that would integrate Monsanto, Bayer said it would grow sales faster than the market and increase its profit margin to “more than 30 percent” after 2020, three years after the merger is slated to be finalized.
Between them, Monsanto and Bayer’s crops division brought in 23.1 billion euros (US$25.8 billion) in sales last year.
Bayer justified the predictions with a “broad product palette and research and development pipeline” for the two companies, adding that the merged firms would bring new products to market faster.
The 58.8-billion-euro deal is the largest takeover in history for a German firm and would create a giant in the agribusiness sector.
However, the tie-up still has to be voted through by Monsanto shareholders and pass regulators’ scrutiny in both Europe and the US.
Environmental groups on both sides of the Atlantic have promised fierce opposition to the deal.
Baumann said the pharmaceuticals division, one of two other major business areas, looked forward to “particularly high growth in sales and margins”.
The prescription medicines unit would target annual sales growth of 6 percent on average until the end of 2018, the firm said, and boost margins to “between 32 and 34 percent” compared with last year’s 30 percent.
Bayer pointed to a stable of five new medications — forecast to bring in 10 billion euros in annual sales, up from 7.5 billion — and a “highly promising” pipeline in the division to explain its optimism.
“By the end of 2023, we are planning to launch at least 20 new products in pharmaceuticals,” Baumann said.
Meanwhile, the consumer health unit aims to increase sales and margins by focusing on its globally-recognized brands, such as Aspirin, and key markets, including the US, Russia, China and Brazil.
Bayer added that the group would “exhaust the potential for licensing previously prescription-only medications for self-medication” as well as developing new digital health offerings.
STEPPING UP: The firm has also asked employees to work in split shifts from this week and to halt all but essential overseas business travel from next month Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) has implemented a remote work policy for employees not on production lines in an attempt to curb the spread of COVID-19, the world’s largest contract chipmaker said yesterday. This is the first time in the Hsinchu-based company’s history that it has launched a large-scale remote work policy, joining global technology companies, such as Apple Inc and Google, that encourage employees to work from home. The chipmaker has also asked employees to work in split shifts from this week, it said. As the number of virus infections continues to climb worldwide, TSMC has urged employees to halt unnecessary
Manufacturers are on a mission to produce desperately needed medical ventilators for the COVID-19 pandemic, even if it means converting assembly lines now making auto parts. Along with a shortage of masks and gloves, the spread of COVID-19 to almost every corner of the globe has highlighted a great need for specialized machines that help keep severely afflicted patients alive. “As the global pandemic evolves, there is unprecedented demand for medical equipment, including ventilators,” GE Healthcare chief executive officer Kieran Murphy said. The group has hired more workers and is making ventilators around the clock. Swedish group Getinge AB is also ramping up output
Facing the rapidly evolving global COVID-19 pandemic, Citibank Taiwan Ltd (台灣花旗) has proactively taken precautionary measures. “The health and safety of our colleagues and their families, as well as our clients and the communities we serve, are of the utmost importance. We continue to take proactive measures to preserve their well-being while we maintain our ability to serve our clients,” Citibank Taiwan chairman Paulus Mok (莫兆鴻) said in a statement yesterday. “We have local and regional contingency plans in place, and we have well-established business continuity plans for the firm. We are monitoring the situation closely, adjusting our operations accordingly,
GoShare, an electric scooter sharing service provider with Gogoro Inc (睿能創意), plans to expand to Tainan next quarter in a strategic alliance with Aeon Motor Co (宏佳騰). The company currently offers its services in Taipei and Taoyuan. “Tainan is very popular among tourists. The city receives an average of 22.94 million tourists every year,” GoShare head Henry Chiang (姜家煒) told a news conference yesterday in Taipei, citing Tourism Bureau statistics. “Besides, the city has a long history of riding scooters,” he said. Each household owns an average of 2.5 scooters, he added. “Expanding presence” is one of four strategies GoShare is adopting for this